Evidence map›Paper›PMID 35816639›Full record

ArticleBlood advances2022

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis.

Ibrahim M Idris, Akib Abba, Jamil A Galadanci, Sani A Aji, Atiku U Jibrilla, Mark Rodeghier, Adetola Kassim, Arthur L Burnett, Michael R DeBaun

Abstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Epidemiology and treatment of priapism in sickle cell disease.Hematology. American Society of Hematology. Education Program · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ibrahim M IdrisDepartment of Haematology, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria.ORCID 0000-0002-8363-3094
Akib AbbaDepartment of Haematology, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria.
Jamil A GaladanciDepartment of Computer Science, Bayero University, Kano, Nigeria.
Sani A AjiDepartment of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria.
Atiku U JibrillaDepartment of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria.
Mark RodeghierMark Consulting, Chicago, IL.ORCID 0000-0001-7258-0073
Adetola KassimDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Arthur L BurnettSchool of Medicine, Johns Hopkins University, Baltimore, MD.
Michael R DeBaunVanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-0574-1604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted one of the first prospective studies to test the hypothesis that the clinical history of priapism underestimates priapism incidence compared with a priapism pain diary. Eligibility criteria were men with sickle cell anemia (SCA) between 18 and 40 years of age who have had at least 3 episodes of priapism in the past 12 months. Seventy-one men with SCA completed the diary for at least 3 months. The first 3 months of the priapism diary were included in the analysis. A total of 298 priapism episodes were recorded, and 80% (57 of 71) of the participants had at least 1 priapism event. Priapism severity was reported in the range of moderate to the worst imaginable pain in 81.5% (263 of 298), and a total 57 participants (80%) had a median pain rating of 6 (interquartile range: 5-8) on a scale from 1 to 10. The monthly incidence rate of priapism per participant based on history versus self-report pain diary was 2.0 (95% confidence interval, 1.9-2.1) and 1.4 (95% confidence interval, 1.2-1.6), respectively (P < .001). For participants that had a prior priapism episode, 80% had another episode during the 3-month interval follow-up. The median time to that second episode was 27.5 days. Major priapism occurred in 9.9% of episodes and was associated with the sum of all prospective priapism events. Men with SCA and at least 3 priapism episodes in the past 12 months are at significant risk for recurrent priapism in the following 3 months.

Indexed as

Anemia, Sickle CellPriapismFemaleHumansIncidenceInfantMalePainProspective Studies

Identifiers

PMID35816639
PMCPMC9582584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.